glp-1 gip therapy effectiveness muscle loss Weight with medicines does not result in a disproportionate loss of mass or function in obese mice and humans: Cell Reports Medicine Normative vs Excess Muscle Loss

Contemporary reviews describe GLP 1 medications as incretin based therapies that produce clinically meaningful HbA1c reductions in trials along with substantial, dose dependent weight loss when prescribed at obesity indicated doses

The Partnership for Safe Medicines (PSM) played a prominent role in the debate, submitting written testimony, providing oral testimony at the hearings, and speaking to the press about the risks of expanding access to untested peptides

Epub 2016 Jun 13

Melanotan-2 vs PT-141: Research Application Comparison Key Takeaways Melanotan-2 binds all five melanocortin receptor subtypes non-selectively, producing simultaneous tanning, appetite suppression, and sexual effects

Only 4 of the 30 people regained weight and chose to return to weekly dosing

We prefer subcutaneous, because it is painless, effective, very easy to do by yourself, and carries no risk of nerve injury